Cargando…

WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability

Detalles Bibliográficos
Autores principales: Zhang, Minghui, Dominguez, Donye, Chen, Siqi, Fan, Jie, Qin, Lei, Long, Alan, Li, Xia, Zhang, Yi, Shi, Huirong, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063034/
https://www.ncbi.nlm.nih.gov/pubmed/30061956
http://dx.doi.org/10.3892/ol.2018.8757
_version_ 1783342484787560448
author Zhang, Minghui
Dominguez, Donye
Chen, Siqi
Fan, Jie
Qin, Lei
Long, Alan
Li, Xia
Zhang, Yi
Shi, Huirong
Zhang, Bin
author_facet Zhang, Minghui
Dominguez, Donye
Chen, Siqi
Fan, Jie
Qin, Lei
Long, Alan
Li, Xia
Zhang, Yi
Shi, Huirong
Zhang, Bin
author_sort Zhang, Minghui
collection PubMed
description
format Online
Article
Text
id pubmed-6063034
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-60630342018-07-30 WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability Zhang, Minghui Dominguez, Donye Chen, Siqi Fan, Jie Qin, Lei Long, Alan Li, Xia Zhang, Yi Shi, Huirong Zhang, Bin Oncol Lett Corrigendum D.A. Spandidos 2018-07 2018-05-21 /pmc/articles/PMC6063034/ /pubmed/30061956 http://dx.doi.org/10.3892/ol.2018.8757 Text en Copyright: © Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Corrigendum
Zhang, Minghui
Dominguez, Donye
Chen, Siqi
Fan, Jie
Qin, Lei
Long, Alan
Li, Xia
Zhang, Yi
Shi, Huirong
Zhang, Bin
WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
title WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
title_full WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
title_fullStr WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
title_full_unstemmed WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
title_short WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
title_sort wee1 inhibition by mk1775 as a single-agent therapy inhibits ovarian cancer viability
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063034/
https://www.ncbi.nlm.nih.gov/pubmed/30061956
http://dx.doi.org/10.3892/ol.2018.8757
work_keys_str_mv AT zhangminghui wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT dominguezdonye wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT chensiqi wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT fanjie wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT qinlei wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT longalan wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT lixia wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT zhangyi wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT shihuirong wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability
AT zhangbin wee1inhibitionbymk1775asasingleagenttherapyinhibitsovariancancerviability